Research Article
Antimicrobial Resistance Profile of Different Clinical Isolates against Third-Generation Cephalosporins
Table 3
Resistance pattern of the different clinical isolates to ceftriaxone.
| Clinical isolates | Resistance pattern | Resistant | Intermediate | Susceptible | Total |
| Citrobacter species | 27(52.9%) | 13(25.5%) | 11(21.6%) | 51 | E. coli | 46 (73.0%) | 3 (4.8%) | 14 (22.2%) | 61 | Enterobacter species | 31 (70.4) | 5(11.4%) | 8(18.2%) | 44 | K. pneumonia | 12 (46.2%) | 4 (15.4%) | 10 (38.4%) | 26 | K. oxytoca | 5 (83.3%) | 0 | 1 (16.7%) | 6 | S. aureus | 11 (4.4%) | 10(4.0%) | 26(10.5%) | 47 | Proteus species | 4 (80%) | 1 (20%) | 0 | 5 | Y. enterocolitica | 4 (66.6%) | 1 (16.7%) | 1 (16.7%) | 6 | Total | 140 (56.5) | 37 (14.9%) | 1 (16.7%) | 248 (100) |
|
|